Lost in translation(and it's this compounding of errors that...)
Navigation Links
Lost in translation
Date:1/7/2009
and it's this compounding of errors that leads to the partially finished protein being tossed into the cellular trash," she adds.
To their further surprise, the ribosome lets go of error-laden proteins 10,000 times faster than it would normally release error-free proteins, a rate of destruction that Green says is "shocking" and reveals just how much of a stickler the ribosome is about high-fidelity protein synthesis.
"These are not subtle numbers," she says, noting that there's a clear biological cost for this ribosomal editing and jettisoning of errors, but a necessary expense.
"The cell is a wasteful system in that it makes something and then says, forget it, throw it out," Green concedes. "But it's evidently worth the waste to increase fidelity. There are places in life where fidelity matters."
'/>"/>
| Contact: Maryalice Yakutchik myakutc1@jhmi.edu 443-287-2251 Johns Hopkins Medical Institutions Source:Eurekalert |
Related biology news :
1. New York Stem Cell Foundation announces third annual Translational Stem Cell Research Conference
2. Study reveals surprising details of the evolution of protein translation
3. NIH expands national consortium dedicated to transforming clinical and translational research
4. Improving care and knowledge in translational research to fight breast cancer
5. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
6. Shilatifard Lab sheds light on molecular machinery required for translation of histone crosstalk
7. AACR, BCRF award inaugural grants in translational breast cancer research
8. NIH awards nearly $23M to University of Chicago for translational research
Post Your Comments:
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Scientists discover gene module underlying atherosclerosis development 2Medicinal products susceptible to dose dumping should be fully tested 58148 157 college presidents declare support for public access to publicly funded research in the US 10057 157 college presidents declare support for public access to publicly funded research in the US 10057 257 college presidents declare support for public access to publicly funded research in the US 10057 3Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics 28TCT 29 Meeting 58143 1Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics 28TCT 29 Meeting 58143 2
Other Biology News:Climate change could be impetus for wars, other conflicts, expert says 2Climate change could be impetus for wars, other conflicts, expert says 3Climate change could be impetus for wars, other conflicts, expert says 4Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage 2Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage 3Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage 4Tahitian vanilla originated in Maya forests, says UC Riverside botanist 2Tahitian vanilla originated in Maya forests, says UC Riverside botanist 3
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
[0] VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291[0] Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock[0] Martek to Announce Fourth Quarter and Fiscal Year 2009 Results[0] Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective
Other Biology Technology:NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 2NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 3NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 4NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 5Children's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership Program 2Bedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers 2
NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza StrainsChildren's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership ProgramBedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |